Advances in Pancreatic Cancer: Exploring Biomarkers and Prognostic Predictors
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Biomarkers".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 490
Special Issue Editor
Special Issue Information
Dear Colleagues,
With our Special Issue, titled "Advances in Pancreatic Cancer: Exploring Biomarkers and Prognostic Predictors", we hope to shape the future of pancreatic cancer care and strive towards improved patient outcomes. For this Special Issue, we invite submissions on cutting-edge research in the field of pancreatic cancer diagnosis and prognosis, thereby contributing to advancements that will ultimately enhance patient prognosis. Topics of interest include the following: novel biomarkers (liquid biopsy, proteomics, metabolomics, etc.); established and emerging prognostic factors (tumor microenvironment, genetic alterations, and inflammatory markers); and their clinical implications for early detection, risk stratification, and personalized management. Submissions in forms of original research articles, reviews, and perspectives are welcome. Please submit your manuscripts by June 2026, so we collectively work toward a brighter future for pancreatic cancer patients.
We look forward to your submissions.
Dr. Makoto Abue
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pancreatic cancer
- biomarkers
- diagnosis
- prognosis
- liquid biopsy
- proteomics
- metabolomics
- tumor microenvironment
- genetic aberrations/mutations
- inflammatory markers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
